Wealthstreet Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,592
Closed -$425K 283
2021
Q1
$425K Buy
8,592
+100
+1% +$4.8K 0.04% 271
2020
Q4
$413K Hold
8,492
0.04% 263
2020
Q3
$426K Hold
8,492
0.05% 240
2020
Q2
$434K Buy
8,492
+300
+4% +$14.6K 0.05% 229
2020
Q1
$358K Hold
8,192
0.05% 225
2019
Q4
$411K Hold
8,192
0.05% 250
2019
Q3
$383K Sell
8,192
-300
-4% -$12.9K 0.05% 251
2019
Q2
$367K Sell
8,492
-1,700
-17% -$72.3K 0.05% 258
2019
Q1
$451K Hold
10,192
0.06% 240
2018
Q4
$427K Sell
10,192
-200
-2% -$8.82K 0.06% 229
2018
Q3
$464K Buy
10,392
+1,300
+14% +$55.5K 0.06% 245
2018
Q2
$364K Sell
9,092
-2,300
-20% -$90.5K 0.05% 264
2018
Q1
$457K Buy
11,392
+2,350
+26% +$97.8K 0.06% 245
2017
Q4
$389K Buy
+9,042
New +$417K 0.05% 257

Other funds holding SNY

Wealthstreet Investment Advisors's SNY Position: Q2 2021 in Review

Wealthstreet Investment Advisors sold out of Sanofi (SNY) in Q2 2021, closing a stake of 8,592 shares — an estimated $425K sold.

Wealthstreet Investment Advisors first reported a position in SNY in Q4 2017 and held it in 14 quarters. The position peaked at $464K in Q3 2018. 586 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

  • Wealthstreet Investment Advisors reported no remaining Sanofi position as of Q2 2021 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 8,592 Sanofi shares in Q2 2021, an estimated $425K.
  • Wealthstreet Investment Advisors first reported a position in Sanofi in Q4 2017 and held it in 14 quarters.
  • Wealthstreet Investment Advisors's Sanofi position peaked at $464K in Q3 2018.
  • 586 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.